Philadelphia, 16 - 17 September 2025

Schedule

Create your personal agenda –check the favourite icon

Sep 168:55
Conference pass

Chair remarks

Keynotes
Julie Huxley-Jones, Vice President, Research, BSMO, Preclinical Technology, Vertex Pharmaceuticals
Sep 169:00
Conference pass

Keynote presentation

Keynotes
Peter Stetson, Chief Health Informatics Officer, Memorial Sloan Kettering Cancer Center
Sep 169:40
Conference pass

The AI-Augmented Clinician: Revolutionizing Care Without Replacing Humans

Keynotes
Sep 1611:40
Conference pass

Chair remarks

Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:40
Conference pass

Chair remarks

AI in Drug Development and Discovery
Sep 1611:40
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1611:40
Conference pass

Chair remarks

Large Language Models
Sep 1611:40
Conference pass

Chair remarks

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1611:40
Conference pass

Chair remarks

Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1611:40
Conference pass
Sep 1611:45
Conference pass

Rare disease discovery infrastructure at a tertiary children’s hospital

Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:45
Conference pass

Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

AI in Drug Development and Discovery
Sep 1611:45
Conference pass

Utilizing large-scale biobank-based human circulating proteomics and genetics to enhance novel therapeutic target discovery

Bioinformatics + in silico R&D
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Sep 1611:45
Conference pass

From Data to Diagnosis: The Impact of Large Language Models in Medical AI

Large Language Models
Hemachandran Kannan, Director, Woxsen University
Sep 1611:45
Conference pass

Risk assessment for prevention

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1611:45
Conference pass

Designing and developing R&D platforms

Data Management, Storage and Architecture
Sep 1611:45
Conference pass

Digital transformation through co-pilots and agile upskilling

Digital Transformation
John Wright, Director of Engineering, Research and Development Informatics, Amgen
Sep 1611:45
Conference pass

A practical look at data governance in life sciences

Data Integration + FAIR
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1611:45
Conference pass

Intelligent Trials: How AI is Redefining the Clinical Research Landscape

AI in Clinical Trials
Sep 1611:45
Conference pass

Preparing the biotech workforce of the future: the role of academic partnerships

Real World Evidence
Sep 1612:05
Conference pass

Project Bridge Proactive genetics: an AI tool to identify patients who would benefit from whole genome sequencing in the outpatient setting

Rare Diseases in Genomics
Matthew Bainbridge, Associate Director of Clinical Genomics Research, Rady Children's Institute for Genomic Medicine
Sep 1612:05
Conference pass

Accelerate Patient Safety Using Knowledge Graphs (S2E1): Risk Factor Analysis at Speed and Scale

Digital Transformation

Systematic analysis of risk factors is a crucial step inidentifyingcontributory elements to adverse events. Relevant data for such analysis such as external and internal safety data warehouses, product labels, industry vocabularies such as WHO Drug Dictionary, and MedDRA, are siloed impeding comprehensive analysis. In this presentation, we discuss details of how a combination of an ontology-based knowledge graph that integrates all this data, MPP-scale graph warehouse, and highly customizable UI with dynamic filtering capabilities enables safety experts to perform risk factor analysis at Wikipedia-scale and sub-minute speeds.

Sep 1612:25
Conference pass

Strategic pipeline development and protaminase strategy for rare disease and integrative genomics

Rare Diseases in Genomics
Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Sep 1612:25
Conference pass

AI in Drug Development

AI in Drug Development and Discovery
Colby Kash, Ceo, Camelot BioCapital
Sep 1612:25
Conference pass

Multi-omics and AI for target identification and validation

Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1612:25
Conference pass

Applications of AI in global investigations

Large Language Models
Sep 1612:25
Conference pass

Oncology Translational Research with Real-World Data and Machine Learning: Study of Resistance to Immune Therapy in Non Small Cell Lung Cancer (NSCLC)

Big Data in Oncology
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Sep 1612:25
Conference pass

AI-Driven Futures: Effective Strategies for Digital Transformation in Healthcare

Digital Transformation
Yaiza Peraza, Data Capabilities Lead, Novo Nordisk
Sep 1612:25
Conference pass

From Complexity to Clarity: Standardizing Data for Innovation in Biotech

Data Management, Storage and Architecture
Kenneth Schwartz, VP, Global Data, Genmab
Sep 1612:25
Conference pass

Pitfalls and Best Practices: Notes from the (research) field

Data Integration + FAIR
Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Sep 1612:25
Conference pass

AI in Clinical Trials

AI in Clinical Trials
Preetha Ram, Managing Partner, Pier 70 Ventures
Sep 1612:25
Conference pass

Real-time prediction of postoperative adverse events in ICU

Real World Evidence
Qingchu Jin, Research Scientist, Northeastern University
Sep 1612:45
Conference pass

High-Throughput Drug Discovery for a Rare Neurological Disorder

Rare Diseases in Genomics
Alex Guin, Director, Computational Biology, Transcripta Bio
Sep 1613:05
Conference pass

Using genetic tools to find a cure for rare diseases

Rare Diseases in Genomics
Xiao Wang, Research Assistant Professor, Univeristy Of Pennsylvania
Sep 1613:05
Conference pass

Native Cell Membrane Nanoparticles System as a platform for membrane protein drug discovery

AI in Drug Development and Discovery
Sep 1613:05
Conference pass

Real World Applications of LLMs in Pharma Commercial

Large Language Models
Sep 1613:05
Conference pass

Harnessing Radiology and Radiomics Data for Data Science

Big Data in Oncology
Fengjian Shi, Product Owner - Oncology Data Science, AstraZencea
Sep 1613:05
Conference pass

Digital transformation in Aggregate Reporting

Digital Transformation
Rupesh Kumar Polupongu, Senior Manager, Global Safety Data Management, Otsuka Pharmaceutical
Sep 1613:05
Conference pass

AI and Quantum Computing as Powerful Allies: Empowering Clinicians Professionals in Clinical Trials and Healthcare Research

AI in Clinical Trials
Sep 1613:05
Conference pass

Leveraging RWD in the Drug Development Process

Real World Evidence
Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk
Sep 1614:25
Conference pass

Chair remarks

AI in Drug Development and Discovery
Sandra Barbosu, Associate Director, Information Technology and Innovation Foundation
Sep 1614:25
Conference pass

Chair remarks

Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:25
Conference pass

Chair remarks

Big Data in Oncology
Puneet Singhal, Executive Director, Merck
Sep 1614:25
Conference pass

Chair remarks

Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1614:25
Conference pass

Chair remarks

Data Management, Storage and Architecture
Vikalp Khare, Director, US Head Safety Data Management, Otsuka Pharmaceutical
Sep 1614:25
Conference pass

Chair remarks

AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:25
Conference pass

Speaker presentation

Real World Evidence
Rebecca Yee, Chief of Microbiology, Assistant Professor of Pathology, The George Washington University
Sep 1614:30
Conference pass

Data, AI and the patient advocate

Rare Diseases in Genomics
Neena Nizar, President and Founder, The Jansens Foundation
Sep 1614:30
Conference pass

Gen AI powering Medical and Patient Safety reviews

AI in Drug Development and Discovery
Sunil Talathi, Senior Director, Data Insights, Data Science & AI, BeOne Medicines
Sep 1614:30
Conference pass

Single cell approaches to tackle tumor clonality in AML

Bioinformatics + in silico R&D
Adam Karami, Head of Bioinformatics, Fels Cancer Institute of Personalized Medicine
Sep 1614:30
Conference pass

Implementing GenAI Sustainably at Enterprise Scale

Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:30
Conference pass

Leveraging pathology translational models for TLS detection in solid tumors

Big Data in Oncology
Meijian Guan, Associate Director Translational Data Science, Genmab
Sep 1614:30
Conference pass

Connected content driving digital transformation

Digital Transformation
Anthony Figorski, Senior Director, Business Transformation, AstraZeneca
Sep 1614:30
Conference pass

Safety Data Management

Data Management, Storage and Architecture
Vikalp Khare, Director, US Head Safety Data Management, Otsuka Pharmaceutical
Sep 1614:30
Conference pass

Developing a harmonized data ecosystem to accelerate cancer research at the Sylvester Comprehensive Cancer Center

Data Integration + FAIR
Vasileios Stathias, Assistant Director, Data Science, UNIVERSITY OF MIAMI
Sep 1614:30
Conference pass

Responsible AI

AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:30
Conference pass

Clinical utility of rapid diagnostics for antimicrobial resistance in infectious diseases

Real World Evidence
Rebecca Yee, Chief of Microbiology, Assistant Professor of Pathology, The George Washington University
Sep 1615:10
Conference pass

Navigating launch challenges in rare disease markets

Rare Diseases in Genomics
Soumavo Sarkar, Director, Novartis
Sep 1615:10
Conference pass

Ethical Innovation: AI and the 3Rs in Modern Drug Discovery

AI in Drug Development and Discovery
Sep 1615:10
Conference pass

GenAI at Scale: Driving Transformative Value and Impact in Medical Affairs

Large Language Models
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Sep 1615:10
Conference pass

DNA Methylation-Mediated Epigenetic Adaptation Promotes Cellular Resilience In AML

Big Data in Oncology
Manna Ahmed, Assistant Research Professor - Manager of The Genomics Resource Facility, Fox Chase Cancer Center
Sep 1615:10
Conference pass

Data and its architecture

Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1615:10
Conference pass

AI-powered multi-omics data integration for predictive modeling of drug actions

Data Integration + FAIR
Lei Xie, Professor, Northeastern University
Sep 1615:10
Conference pass

AI based first draft document authoring in support of clinical trials

AI in Clinical Trials
Chris Willis, Director, Emerging Method & Technologies - Research IT, Bristol Myers Squibb
Sep 1615:10
Conference pass

Advancing the Clinical Trial Ecosystem: MENA’s Strategic Role in Enhancing Global Inclusivity

Real World Evidence
Huda Eldosougi, Chief Technical Advisor, Saudi Food and Drug Authority
Sep 1615:30
Conference pass

Sponsored presentation

AI in Drug Development and Discovery
Sep 1615:30
Conference pass

Filtering the landscape

Big Data in Oncology
Maria Movafegh, Oncology Competitive Intelligence Director, GSK
Sep 1615:50
Conference pass

Clinical Unknowns, Genomic Answers: Improving Diagnostic Yield in Rare Disease

Rare Diseases in Genomics
Michaëlle Cherisol, Physician Writer, Harvard Medical School
Sep 1615:50
Conference pass

Scaling Generative AI across R&D and Moving Towards Agentic AI and beyond

AI in Drug Development and Discovery
Mariam Ahmed, Global R&D IT - Director Generative AI Product Lead, AstraZeneca
Sep 1615:50
Conference pass

Generative AI driven clinical trials

Large Language Models
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Sep 1615:50
Conference pass

Translating big data into target optimization and discovery in oncology and beyond

Big Data in Oncology
Jenna Aronson, Principal, Two Bear Capital
Sep 1615:50
Conference pass

Lab Automation & AI Accelerated Drug Discovery

Digital Transformation
Peter Clark, Vice President, Digital Chemistry & Design, Novo Nordisk
Sep 1615:50
Conference pass

The Data Dilemma: Storage, Management, and the Privacy Puzzle

Data Management, Storage and Architecture
Sep 1615:50
Conference pass

Seamlessly Connecting the Dots: Advancing Data Integration for Precision Medicine and Drug Discovery

Data Integration + FAIR
Craig Stanley, VP Data Strategy and Technical Operations, Institute for Neurodegenerative Disorders
Sep 1615:50
Conference pass

AI, Real-World Evidence, and the Future of HTA: From Data Generation to Reimbursement Decisions

Real World Evidence
Thani Jambulingam, Professor of Food, Pharma and Healthcare Business, Saint Joseph's University
Sep 1616:40
Conference pass

Chair remarks

Rare Diseases in Genomics
Sarath Babu Krishna Murthy, Director of Genomic Health & Informatics, Columbia university medical center
Sep 1616:40
Conference pass

Chair remarks

AI in Drug Development and Discovery
Pravin Kaumaya, Professor & Director, Indiana university School of Medicine
Sep 1616:40
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Lana Garmire, Associate Professor, Univ of Michigan
Sep 1616:40
Conference pass
Sep 1616:40
Conference pass

Chair remarks

Big Data in Oncology
Puneet Singhal, Executive Director, Merck
Sep 1616:40
Conference pass

Chair remarks

Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1616:40
Conference pass

Chair remarks

AI in Clinical Trials
Vivek Suryanarayanan, Product Management, Takeda
Sep 1616:45
Conference pass

Insilico approaches for repurposing drugs

AI in Drug Development and Discovery
Youyi Peng, Senior Bioinformatics Specialist, Rutgers University
Sep 1616:45
Conference pass

Personalized drug repurposing using spatial transcriptomics data

Bioinformatics + in silico R&D
Lana Garmire, Associate Professor, Univ of Michigan
Sep 1616:45
Conference pass

The journey of Takeda connected clinical systems and use of practical AI

Large Language Models
Harish Manmathan, Director of Clinical Data Engineering, Takeda
Sep 1616:45
Conference pass
Sep 1616:45
Conference pass

Digital transformation planning and stakeholder buy in

Digital Transformation
Sep 1616:45
Conference pass

Health Data as Infrastructure: Designing Interfaces for Trust Across Borders, Systems, and Generations

Data Management, Storage and Architecture
Linxin Gu, Founder and CEO, TechConnect
Sep 1616:45
Conference pass

AI based Protocol Optimization informing Protocol amendments

AI in Clinical Trials
Mukul Virmani, Director, Clinical Data Science, AI Research Center, Gilead Sciences, Inc.
Sep 1616:45
Conference pass

Understanding complex diseases to identify the right targets

Real World Evidence
Michael Liebman, Managing Director and Co-Founder, IPQ Analytics, LLC
Sep 1617:05
Conference pass

Enterprise applications of LLM in pharma

Large Language Models
Shams Zaman, Senior Director, Global Biometrics & Data Sciences, bristol-myers squibb
Sep 1617:05
Conference pass

Unlocking the Potential of AI for High-Throughput Immunotherapy Drug Discovery Through RNA Splicing

Big Data in Oncology

Envisagenics introduces SpliceCore, an AI-driven platform designed to identify novel, tumor-specific epitopes for immunotherapy leveraging thousands of RNA sequencing data sets from diseased and healthy tissues. This presentation explores the new frontier of therapeutic target discovery harnessing the untapped potential of RNA alternative splicing and the power of the AI algorithms that constitute the SpliceCore platform. Case studies and experimental validations will be presented highlighting SpliceCore’s ability to identify novel therapeutic targets for the development of the next generation of highly efficacious and safe precision therapies.

Sep 1617:25
Conference pass

Data in rare disease and the changing landscape

Rare Diseases in Genomics
Moderator: Neena Nizar, President and Founder, The Jansens Foundation
Molly Martell, Entrepreneur in Residence, Digital DX Ventures
Matthew Bainbridge, Associate Director of Clinical Genomics Research, Rady Children's Institute for Genomic Medicine
Steven Ferguson, Special Advisor, NIH Office of Technology Transfer
Sep 1617:25
Conference pass

From Bench to Bedside: How AI is Accelerating Drug Development

AI in Drug Development and Discovery
Meijian Guan, Associate Director Translational Data Science, Genmab
Sunil Talathi, Senior Director, Data Insights, Data Science & AI, BeOne Medicines
Jan-Samuel Wagner, Director, Head of Natural Language Processing, Genmab
Moderator: Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Sep 1617:25
Conference pass

Using bioinformatics + InSilco to optimise research and development

Bioinformatics + in silico R&D
Deidre Dalmas Wilk, Scientific Director, Global Investigative Safety, Nonclinical Safety Project Lead, GSK
Alex Guin, Director, Computational Biology, Transcripta Bio
MaryLena Bleile, Biomarker Statistician, SANOFI
Lana Garmire, Associate Professor, Univ of Michigan
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Sep 1617:25
Conference pass

Generative AI in healthcare

Large Language Models
Moderator: Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Sep 1617:25
Conference pass

Bringing together disbarred data in oncology

Big Data in Oncology
Moderator: Paul Petraro, Head Real-World Evidence Analytic COE, Global Medical Affairs, Boehringer Ingelheim Pharma Inc.
Jenna Aronson, Principal, Two Bear Capital
Maria Movafegh, Oncology Competitive Intelligence Director, GSK
Sep 1617:25
Conference pass

Challenges in global systems implementation and integration

Data Management, Storage and Architecture
Sep 1617:25
Conference pass

Digital transformation in life science companies

Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1617:25
Conference pass

Enhancing FAIR – Successes and Failures

Data Integration + FAIR
Moderator: Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1617:25
Conference pass

Current regulatory standards within AI adoption and its reflection in clinical trial development and execution

AI in Clinical Trials
Moderator: Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Kevin Stevens, Head, Global Regulatory Affairs Device, PDT, Takeda
Vivek Suryanarayanan, Product Management, Takeda
Daya Shankar, Dean, School of Sciences and Founder VaidyaAI, Woxsen University
Sep 1617:25
Conference pass

Leveraging RWE data to improve health equity

Real World Evidence

Create your personal agenda –check the favourite icon

Sep 179:20
Conference pass

Designing Data Platforms to Enable AI in Revolutionize R&D

Keynotes
Sabyasachi Dasgupta, Global Head of R&D Data Platforms & Products, Sanofi
Sep 179:40
Conference pass

Investor Panel: The Future of Healthcare Investing: Navigating Innovation and Impact

Keynotes
Sarah Johnson, Partner, Advantary Capital Partners
Preetha Ram, Managing Partner, Pier 70 Ventures
Sally Wang Liang, Venture Partner, Highlight Capital
Pooja Majmudar, Investment Partner, KELES Digital Health
Sep 1711:40
Conference pass

Chair remarks

AI in Drug Development and Discovery
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Sep 1711:40
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Qingchu Jin, Research Scientist, Northeastern University
Sep 1711:40
Conference pass

Chair remarks

Digital Transformation
Linxin Gu, Founder and CEO, TechConnect
Sep 1711:40
Conference pass

Chair remarks

Data Management, Storage and Architecture
Paul Petraro, Head Real-World Evidence Analytic COE, Global Medical Affairs, Boehringer Ingelheim Pharma Inc.
Sep 1711:40
Conference pass

Chair remarks

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:40
Conference pass

Chair remarks

AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1711:40
Conference pass

Chair remarks

Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, AbbVie
Sep 1711:40
Conference pass

Chair remarks

Innovation
Soumavo Sarkar, Director, Novartis
Sep 1711:45
Conference pass

Applications for future use of AI

AI in Drug Development and Discovery
Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Sep 1711:45
Conference pass

Building AI Drug Discovery Capabilities in Academia

Bioinformatics + in silico R&D
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Sep 1711:45
Conference pass

LLMs in Community Healthcare: Practical Impact and Adoption

Large Language Models
Joseph Izzo, Chief Medical Information Officer, San Joaquin General Hospital
Sep 1711:45
Conference pass

Digital transformation in biotherapeutics discovery

Digital Transformation
Alexander Horspool, Associate Director of Data and Laboratory Automation in Biotherapeutics Discovery, Boehringer Ingelheim
Sep 1711:45
Conference pass

From Silos to Synergy: Building Scalable, FAIR Data Ecosystems in Biotech

Data Management, Storage and Architecture
Sep 1711:45
Conference pass

FAIR for the People: Change Management for Reluctant Participants

Data Integration + FAIR

FAIR-ification of data is an established goal in many industries, but managing the changes needed at the user level can be a challenge. Often, FAIR-enabling changes are made at the beginning of the pipeline, but the employees who benefit are at the end of it. What should you do to get everyone on board?

Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass

Optimizing clinical trial delivery with gen AI

AI in Clinical Trials
Vivek Suryanarayanan, Product Management, Takeda
Sep 1711:45
Conference pass

Prognostic Impact of MAGE-A4 Expression, HLA Subtype, and Patterns of Systemic Treatment in Patients with Metastatic Synovial Sarcoma: Implications for T-Cell Therapy

Real World Evidence
Sep 1711:45
Conference pass

How we utilise AI in liquid biopsy

Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, AbbVie
Sep 1712:05
Conference pass

AI in clinical trials – lessons learnt

AI in Clinical Trials
Jan-Samuel Wagner, Director, Head of Natural Language Processing, Genmab
Sep 1712:05
Conference pass

Systematic Discovery of Hidden Patterns in Scientific Data: Case Studies Across Domains

Innovation
Jessica Rumbelow, Co-founder & CEO, Leap Labs
Sep 1712:25
Conference pass

Best practice for partnering with CRO’s to integrate AI

AI in Drug Development and Discovery
Sep 1712:25
Conference pass

Large-scale analysis of X chromosome highlights opportunities for novel drug target discovery

Bioinformatics + in silico R&D
Morgan Howard, Scientist, Genomics Discovery, Foresite Labs
Sep 1712:25
Conference pass

Integration of LLMs with the drug discovery development

Large Language Models
Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology, AstraZeneca
Sep 1712:25
Conference pass

Cell Painting Gallery: an open resource for image-based profiling

Data Management, Storage and Architecture
Sep 1712:25
Conference pass

Digital twins into manufacturing

Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sep 1712:25
Conference pass

Navigating R&D informatics

Data Integration + FAIR
Kyle Vick, Associate Director of Research Informatics, SpringWorks Therapeutics
Sep 1712:25
Conference pass

AI and precision medicine for clinical trial development

AI in Clinical Trials
Yilin Xu, Head of clinical data analytics, AbbVie
Sep 1712:25
Conference pass

AI to advance the utility of real-world evidence

Real World Evidence
Hong Truong, Principal, Define Ventures
Sep 1712:25
Conference pass

Current state of precision medicine and liquid biopsy and where it is going

Precision Medicine and Liquid Biopsy
Simeón Baker, Executive Director of External Affairs, Genomics England
Sep 1712:25
Conference pass

Integrated precision medicine solutions for rare diseases

Innovation
Joshua Resnikoff, CEO and Cofounder, TMA Precision Health
Sep 1713:05
Conference pass

Revolutionizing Drug Development: The Role of AI in Accelerating Discovery and Precision Medicine

AI in Drug Development and Discovery
Vineet Jain, IT Partner, Bristol Myers Squibb
Sep 1713:05
Conference pass

Causal reinforcement learning in drug development

Bioinformatics + in silico R&D
MaryLena Bleile, Biomarker Statistician, SANOFI
Sep 1713:05
Conference pass

Advancing Personalization in Healthcare Professional Omnichannel Communications

Digital Transformation
Donna Judd, Medical Channel Strategy & Engagement Lead, Pfizer
Sep 1713:05
Conference pass

Data integration for better decision making

Data Integration + FAIR
Sep 1713:05
Conference pass

Applying machine learning to predict enrolment likelihood and clinical site

AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1713:05
Conference pass

Real world evidence in precision medicine development

Real World Evidence
Molly Martell, Entrepreneur in Residence, Digital DX Ventures
Sep 1713:05
Conference pass

Using genomics and AI to find the best risk profile for each patient

Precision Medicine and Liquid Biopsy
Kuan-lin Huang, Associate Professor, Icahn School of Medicine at Mount Sinai
Sep 1714:25
Conference pass

Chair remarks

AI in Drug Development and Discovery
Ari Allyn-Feuer, Director of Artificial Intelligence Product, GSK
Sep 1714:25
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Qingchu Jin, Research Scientist, Northeastern University
Sep 1714:25
Conference pass

Chair remarks

Digital Transformation
Linxin Gu, Founder and CEO, TechConnect
Sep 1714:25
Conference pass

Chair remarks

Data Management, Storage and Architecture
Paul Petraro, Head Real-World Evidence Analytic COE, Global Medical Affairs, Boehringer Ingelheim Pharma Inc.
Sep 1714:25
Conference pass

Chair remarks

Data Integration + FAIR
Philip Brown, Senior Data Engineer, SANOFI
Sep 1714:25
Conference pass

Chair remarks

AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1714:25
Conference pass

Chair remarks

Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, AbbVie
Sep 1714:25
Conference pass

Chair remarks

Innovation
Soumavo Sarkar, Director, Novartis
Sep 1714:30
Conference pass

How VCs drive growth in drug development and discovery

AI in Drug Development and Discovery
Sep 1714:30
Conference pass

Unveiling secrets of multi omics data in cancer research hospital environments

Bioinformatics + in silico R&D
Michael Tolstorukov, Director, Bioinformatics and Molecular Data, Dana-Farber Cancer Institute
Sep 1714:30
Conference pass

The road to clinical speech and language analysis

Large Language Models
Sep 1714:30
Conference pass

Speaker presentation

Data Management, Storage and Architecture
Sep 1714:30
Conference pass

Electronic batch record data translation

Data Integration + FAIR
Philip Brown, Senior Data Engineer, SANOFI
Sep 1714:30
Conference pass
Sep 1714:30
Conference pass

Empowering Sites and Patients: A Visualization Strategy in Clinical Trials

Real World Evidence
Betsy luo, IT Business Analyst, Astrazeneca
Sep 1714:30
Conference pass

Digital and computational pathology in clinical medicin

Precision Medicine and Liquid Biopsy
Nirmit Kumar, Senior Global Medical Strategy Leader, AstraZeneca
Sep 1714:50
Conference pass

Use cases for acceleration of clinical trials

Large Language Models
Amir Emadzadeh, Director, Genentech
Sep 1715:10
Conference pass

Harnessing AI to Bridge Skills Gaps and Drive Smart Biomanufacturing: Preparing the Biopharma Workforce for the Future of Drug Development

AI in Drug Development and Discovery
Sep 1715:10
Conference pass

Translating Computational Predictions into Clinical Impact: Multiomics Biomarker Validation for Drug Development and Stratified Care

Bioinformatics + in silico R&D
Roya Khosravi-Far, CEO, InnoTech Precision Medicine, Inc.
Sep 1715:10
Conference pass

Advancing care for animals in Zoetis through digital transformation

Digital Transformation
Susan Huse, Research Director, Zoetis
Sep 1715:10
Conference pass

Clinical trials implementation

Data Integration + FAIR
Sep 1715:10
Conference pass

Accelerated Approval Modeling in Clinical Trials

AI in Clinical Trials
Sep 1715:10
Conference pass

Potential paradigm shift in immune-oncology strategies: Synergistic combination of B-cell epitope peptide vaccines and immune checkpoint inhibitor (PD-1, PD-L1, CTLA-4, TIGIT and VEGF) vaccines

Precision Medicine and Liquid Biopsy
Pravin Kaumaya, Professor & Director, Indiana university School of Medicine
last published: 08/Jul/25 15:56 GMT

Get involved at BioTechX USA

 

 

TO SPONSOR


Jamie Blowfield

jamie.blowfield@terrapinn.com

 

TO SPEAK


Anna Abiola
anna.abiola@terrapinn.com

 

MARKETING OPPORTUNITIES


Karen Duncan

karen.duncan@terrapinn.com